What happened
HEM Pharma updated a previously disclosed supply contract with access business group, now worth US$3.45M, about 35.63% of its recent annual revenue, running through Feb 2027.
For context, this single contract equals about 35.63% of the company's most recent annual revenue.
| Counterparty | access business group |
|---|---|
| Contract value | US$3.45M |
| vs. recent revenue | 35.63% |
| Through | Feb 2027 (from Jun 2026) |
| Filed | 2026-09-09, [Amended] Supply contract signed |
| Source | DART rcept 20260909900595 → open original filing |
Versions of this filing
- 2026-06-24Original
- 2026-09-04Amendment 1
- 2026-09-09Amendment 2 (this page)
Source: DART. Information only, not investment advice.